How do you counsel/advise patients when asked to compare ultrahypofractionated radiotherapy with the TULSA procedure?  

I start by noting that the three NCCN-guideline recommended management plans for favorable-risk prostate cancer are radiotherapy (including SBRT), surgery, and active surveillance, and the latter two often require additional local therapy to render a patient cured within the next 5-10 years. In gene...